ArticleFrontiers in public health2025
Depression, anxiety, burnout, and substance use disorders among auto workers and COVID-19 as a stressor in Mexico.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The COVID-19 pandemic intensified psychosocial risks, exposing vulnerabilities in labor conditions. Findings aim to inform mental health interventions and workplace policies tailored to industrial workers in post-pandemic settings. Methods: We evaluated the prevalence of occupational stress and associated psychiatric problems, including anxiety, depression, substance use disorders, and burnout among automotive workers, examining COVID-19 as a significant stressor. Participants were workers in the automotive industry ( Results: Multinomial logistic regression was used to examine the associations between COVID-19 stressors and mental health symptoms, while adjusting for sociodemographic characteristics. Prevalence rates were 311 (30.5%) for burnout, 299 (29.3%) for anxiety symptoms, 248 (24.3%) for depressive symptoms, and 142 (13.9%) for substance use problems. Experiencing COVID-19 stressors (adjusted odds ratio (AOR): 2.65, 95% CI: 1.26-3.26) and feeling vulnerable to infection (AOR: 3.34, 95% CI: 2.17-4.06) significantly increased the odds of having comorbid anxiety and depressive symptoms, as well as burnout, compared to workers without these stressors. Despite 763 (74.8%) of workers reporting feeling supported by their company to seek psychological help, only 259 (25.3%) had received mental health treatment in the past year. Discussions: These findings demonstrate that COVID-19-related stressors significantly impacted automotive workers' mental health. The substantial gap between symptom prevalence and treatment-seeking, despite perceived workplace support, highlights the need for proactive mental health interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.